238 related articles for article (PubMed ID: 1666286)
1. Peptide inhibitors and the active site(s) of angiotensin converting enzyme.
Riordan JF; Chen YN; Kleemann SG; Bünning P
Biomed Biochim Acta; 1991; 50(4-6):809-14. PubMed ID: 1666286
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin-converting enzyme: zinc- and inhibitor-binding stoichiometries of the somatic and testis isozymes.
Ehlers MR; Riordan JF
Biochemistry; 1991 Jul; 30(29):7118-26. PubMed ID: 1649623
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin-converting enzyme-2 (ACE2): comparative modeling of the active site, specificity requirements, and chloride dependence.
Guy JL; Jackson RM; Acharya KR; Sturrock ED; Hooper NM; Turner AJ
Biochemistry; 2003 Nov; 42(45):13185-92. PubMed ID: 14609329
[TBL] [Abstract][Full Text] [Related]
4. [Angiotensin converting enzyme (kininase II). Molecular and physiological aspects].
Costerousse O; Jaspard E; Allegrini J; Wei L; Alhenc-Gelas F
C R Seances Soc Biol Fil; 1992; 186(6):586-98. PubMed ID: 1339589
[TBL] [Abstract][Full Text] [Related]
5. Shedding of somatic angiotensin-converting enzyme (ACE) is inefficient compared with testis ACE despite cleavage at identical stalk sites.
Woodman ZL; Oppong SY; Cook S; Hooper NM; Schwager SL; Brandt WF; Ehlers MR; Sturrock ED
Biochem J; 2000 May; 347 Pt 3(Pt 3):711-8. PubMed ID: 10769174
[TBL] [Abstract][Full Text] [Related]
6. Crystal structure of the human angiotensin-converting enzyme-lisinopril complex.
Natesh R; Schwager SL; Sturrock ED; Acharya KR
Nature; 2003 Jan; 421(6922):551-4. PubMed ID: 12540854
[TBL] [Abstract][Full Text] [Related]
7. A comparison of the zinc contents and substrate specificities of the endothelial and testicular forms of porcine angiotensin converting enzyme and the preparation of isoenzyme-specific antisera.
Williams TA; Barnes K; Kenny AJ; Turner AJ; Hooper NM
Biochem J; 1992 Dec; 288 ( Pt 3)(Pt 3):875-81. PubMed ID: 1335236
[TBL] [Abstract][Full Text] [Related]
8. Two binding sites on angiotensin-converting enzyme: evidence from radioligand binding studies.
Perich RB; Jackson B; Rogerson F; Mendelsohn FA; Paxton D; Johnston CI
Mol Pharmacol; 1992 Aug; 42(2):286-93. PubMed ID: 1325031
[TBL] [Abstract][Full Text] [Related]
9. The angiotensin I-converting enzyme (kininase II): progress in molecular and genetic structure.
Alhenc-Gelas F; Soubrier F; Hubert C; Allegrini J; Lattion AL; Corvol P
J Cardiovasc Pharmacol; 1990; 15 Suppl 6():S25-9. PubMed ID: 1697357
[TBL] [Abstract][Full Text] [Related]
10. Molecular cloning of human testicular angiotensin-converting enzyme: the testis isozyme is identical to the C-terminal half of endothelial angiotensin-converting enzyme.
Ehlers MR; Fox EA; Strydom DJ; Riordan JF
Proc Natl Acad Sci U S A; 1989 Oct; 86(20):7741-5. PubMed ID: 2554286
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory antibodies to human angiotensin-converting enzyme: fine epitope mapping and mechanism of action.
Skirgello OE; Balyasnikova IV; Binevski PV; Sun ZL; Baskin II; Palyulin VA; Nesterovitch AB; Albrecht RF; Kost OA; Danilov SM
Biochemistry; 2006 Apr; 45(15):4831-47. PubMed ID: 16605251
[TBL] [Abstract][Full Text] [Related]
12. Chicken lacks the testis specific isozyme of angiotensin converting enzyme found in mammals.
Esther CR; Thomas KE; Bernstein KE
Biochem Biophys Res Commun; 1994 Dec; 205(3):1916-21. PubMed ID: 7811282
[TBL] [Abstract][Full Text] [Related]
13. A comparison of guinea pig serum angiotensin converting enzyme with forms of angiotensin converting enzyme from human, rat and rabbit tissues.
Ryan JW; Valido FA; Chung AY; Ripka JE; Peterson CM; Urry RL
Biochem Biophys Res Commun; 1993 Oct; 196(2):509-14. PubMed ID: 8240321
[TBL] [Abstract][Full Text] [Related]
14. Simulated interactions between angiotensin-converting enzyme and substrate gonadotropin-releasing hormone: novel insights into domain selectivity.
Papakyriakou A; Spyroulias GA; Sturrock ED; Manessi-Zoupa E; Cordopatis P
Biochemistry; 2007 Jul; 46(30):8753-65. PubMed ID: 17605472
[TBL] [Abstract][Full Text] [Related]
15. Crystal structure of the N domain of human somatic angiotensin I-converting enzyme provides a structural basis for domain-specific inhibitor design.
Corradi HR; Schwager SL; Nchinda AT; Sturrock ED; Acharya KR
J Mol Biol; 2006 Mar; 357(3):964-74. PubMed ID: 16476442
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of angiotensin converting enzyme (ACE) in plasma and tissues: studies ex vivo after administration of ACE inhibitors.
Johnston CI; Mendelsohn FA; Cubela RB; Jackson B; Kohzuki M; Fabris B
J Hypertens Suppl; 1988 Dec; 6(3):S17-22. PubMed ID: 2852234
[TBL] [Abstract][Full Text] [Related]
17. Optimal recognition of neutral endopeptidase and angiotensin-converting enzyme active sites by mercaptoacyldipeptides as a means to design potent dual inhibitors.
Coric P; Turcaud S; Meudal H; Roques BP; Fournie-Zaluski MC
J Med Chem; 1996 Mar; 39(6):1210-9. PubMed ID: 8632427
[TBL] [Abstract][Full Text] [Related]
18. Molecular heterogeneity of angiotensin converting enzyme in human cerebrospinal fluid.
Lantz I; Nyberg F; Terenius L
Biochem Int; 1991 Mar; 23(5):941-8. PubMed ID: 1715707
[TBL] [Abstract][Full Text] [Related]
19. Identification of essential tyrosine and lysine residues in angiotensin converting enzyme: evidence for a single active site.
Chen YN; Riordan JF
Biochemistry; 1990 Nov; 29(46):10493-8. PubMed ID: 2176870
[TBL] [Abstract][Full Text] [Related]
20. Effect of zinc depletion on angiotensin I-converting enzyme in arterial walls and plasma of the rat.
Dahlheim H; White CL; Rothemund J; von Lutterotti N; Jacob IC; Rosenthal J
Miner Electrolyte Metab; 1989; 15(3):125-9. PubMed ID: 2542744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
